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predominantly muscle-specific UCP3 and brain-specific UCP4, and BMCP (or UCP5) form a gene subfamily within the mitochondrial anion carrier gene family together with "classic," brown adipose tissue-specific UCP1 and at least three distinct plant UCPs (1, 2) . Three basic physiological roles of all UCPs should be manifested as consequences of low uncoupling states (2) : (i) a slight acceleration of metabolism caused by slightly increased respiration, (ii) a concomitant reduction in reactive oxygen species (ROS) formation (3, 4) , and (iii) inevitably related, mild thermogenesis. In addition, UCP2 (UCP3) most probably possesses more specific physiological roles (2, (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) in defense against excessive ROS production (2-5), in participation in body weight regulation (5) (6) (7) (8) 13) ; in heat production during various types of adaptive thermogenesis (8, 9, 14) , including fever (9) , and in switching between pro-and antiapoptotic processes (15) . Pathologically distorted regulations of UCP2 (UCP3) expression or distorted ligand regulations are most probably among the causes of the development of obesity (13) , type 2 diabetes (16), heart failure (5), and aging.
The diverse UCPn functions require fine-tuned regulations that can be accomplished only by regulation and up-regulation of their transcription (e.g. see Refs. 5, 8, 9, 14, 17, 18) and by down-regulation of their translation (19) . Biochemical regulation, i.e. regulation by ligands, cofactors, or by covalent modification are also likely involved. The first line of regulation could be provided by FAs (20) . It has been established that, like UCP1 and plant UCP (PUMP), UCP2 and UCP3 are also activated by FAs (20, 21) , most probably because of the FA cycling mechanism (20, (22) (23) (24) . Hence, the availability of free FAs is the first prerequisite for UCP function. Second, purine nucleotides (PN) were confirmed to inhibit the protonophoric action of reconstituted Escherichia coli-expressed UCP2 or UCP3. Garlid and co-workers (20) observed a lower PN affinity toward UCP2 and UCP3 in sulfate media (20) , whereas Klingenberg and co-workers (21) reported a higher affinity in low salt medium. Modulation, i.e. the lowering of PN inhibition by some yet unknown factors, may represent the mechanism that activates UCP2-or UCP3-mediated uncoupling in vivo. Such well known modulators for UCP1 are alkaline pH and Mg 2ϩ (24, 25) . Also, cofactors like coenzyme Q 10 (21, 26) and superoxide (27) were suggested to activate UCP2 (UCP3). Coenzyme Q 10 was claimed to be required to restore the intact conformation of recombinant UCPs solubilized by sarcosinate from inclusion bodies (21, 26) . Even native UCP2 (UCP3) was reported to be stimulated upon superoxide generation in various types of mitochondria (27) . UCP2 (UCP3) in this presumably stimulated state was inhibited by ATP, ADP, GTP, and GDP in kidney or skeletal muscle mitochondria (27) . These results suggested that native UCP2 (UCP3) could also be inhibited by PN. Recently, fluorescent nucleotide derivatives were demonstrated to interact with E. coli-expressed UCP2 (28) , but direct measurements with native nucleotides were still lacking.
Most initial studies of recombinant UCP2 and UCP3 expressed in yeast were performed while monitoring coupling in yeast mitochondria (6 -8) . However, available reports contain numerous contradictory results (29 -36) . Claims were made that UCP2 is specifically activated (state 4 respiration in yeast mitochondria is stimulated) by all-trans-retinoic acid and that it is insensitive to palmitic acid, 9-cis-retinoic acid, and other FAs tested including arachidonic, linoleic, docosahexaenoic acid, and prostaglandin E2 (36) . It is difficult to imagine a physicochemical basis for this strange FA specificity, which is incompatible with previous surveys of FAs interacting with UCP1 (37, 38) .
Hence, in this work we have studied reconstituted yeastexpressed UCP2 and UCP3 in their partially purified (but highly active) form, in order to screen in detail their natural ligands, FAs and PN. We have clearly demonstrated that all natural long chain FAs, saturated or unsaturated, activate UCP2-or UCP3-mediated H ϩ translocation. From kinetics of putative FA cycling we have found the highest apparent affinity to UCP2 (lowest K m ) for two -6 polyunsaturated FAs, which are also the most potent agonists of PPAR␤ (17) . This finding suggests their possible dual role in activating both UCP expression and uncoupling activity. We have also shown that the apparent affinity to UCP2 (reciprocal K i ) is decreasing in order: ADP Ͼ ATP ϳ GTP Ͼ GDP Ͼ Ͼ AMP. 
EXPERIMENTAL PROCEDURES
Most of the chemicals were purchased from Sigma.
3 H-labeled nucleotides were from Amersham Biosciences. Hydroxylapatite, BioGel HTP, and Bio-Beads SM2 were from Bio-Rad. Octylpentaoxyethylene (OctylPOE) was from Bachem Feinchemikalien, Bubendorf, Switzerland. Materials for reconstitution were from the same sources as described elsewhere (39) , materials for yeast fermentation were from Difco. Zymolyase 100T was from ICN. All other chemicals were reagent grade.
Yeast Expression of UCP2 and UCP3-W303 yeast containing pCGS110 (or pYES) vectors with inserted cDNAs coding for human UCP2 and human UCP3 under control of an inducible Gal promoter and ura Ϫ selection were donated by Ruth E. Gimeno and Louis A. Tartaglia (Millennium Pharmaceuticals, Inc., Cambridge, MA; Ref. 6). cDNA coding for UCP1 in pCGS110 vector contained in JB516 yeast was from Prof. Karl Freeman (McMaster University, Hamilton, Ontario, Canada; Ref. 40) . Yeast cells were grown on ura Ϫ selective plates and were inoculated into 4 -8 250-ml Erlenmeyer flasks with a medium containing 203 mM (1.5 vol%) lactate, 0.05% glucose, 0.17% yeast nitrogen base (Difco) 0.5% ammonium sulfate, 0.005% each of L-aminoacids (tryptophan, methionine, arginine, leucine, histidine), and adenine sulfate. After 24 h, 0.2% galactose was added, and cells were shaken for another 24 -28 h until the optical density of 1 was achieved. Mitochondria were prepared immediately after terminating fermentation using Zymolyase 100T (ICN) to cleave the cell wall (40). Protein extraction followed immediately. Changes in different fermentation yields were compensated by taking the same amount of yeast mitochondrial protein, usually 30 mg. 41 ). The cells were grown at 30°C to an OD 600 of 0.6 and then induced with 1 mM isopropyl-1-thio-␤-D-galactopyranoside at 30°C for 6 h. Cells from a 700-ml culture were lysed in a French Press in 20 ml of lysis buffer (10 mM Tris, pH 7, 1 mM EDTA, 1 mM dithiothreitol); the lysate was centrifuged at 27,000 ϫ g for 15 min, and the pellet was resuspended in 20 ml of the lysis buffer and centrifuged at 1000 ϫ g for 3 min. 1-ml aliquots of the supernatant were centrifuged at 14,000 ϫ g for 15 min. The resulting pelleted inclusion bodies were stored frozen at Ϫ70°C. When used, they were suspended (3 mg of protein) and washed two times in 10 mM Tris-Cl, 0.1 mM Tris-EDTA, pH 7.0. The washed pellet was solubilized in 0.75 ml of 5 mM TEA-TES, 30 mM TEA 2 SO 4 , 0.1 mM Tris-EDTA, pH 7.2, containing 1.67% sodium lauroylsarcosinate (SLS) and 1% octylpentaoxyethylene. The resulted micellar solution was concentrated (thus partly depleted of SLS) and subsequently diluted (usually 1:1) in 20 mM Na-MES, pH 6. Protein content was estimated using the Amido Black method (42) .
E. coli Expression of UCP2 and UCP3-Bacterial
Isolation and Reconstitution of Yeast-expressed UCP2/UCP3-Reconstitution with lipid protection was adopted from Klingenberg and Winkler (43) to comply with 6-methoxy-N-(3-sulfopropyl)quinolinium (SPQ) fluorescent monitoring of ion fluxes (20, 22, 23, 37, 39) . It included OctylPOE extraction of yeast mitochondria (30 mg of protein) under lipid protection, the isolation step on HTP, detergent removal on Bio-Beads SM2 overnight, and washing of external probe Sephadex G25-300. The total amount of added lipid was 40.7 mg (egg yolk lecithin, type XI-E, Sigma, 4% cardiolipin and 1.6% L-␣-phosphatidic acid). Additional lipids in 1 ml of final suspension, up to 20 mg, could have originated from the mitochondria. The internal medium for liposomes contained 84.4 mM TEA 2 SO 4 , 28.8 mM TEA-TES with 9.2 mM TEA, pH 7.2, 0.6 mM TEA-EGTA. The protein content of liposomes was also estimated by the Amido Black method (42) . Usually, a lipid-to-protein ratio of about 1000 or higher was obtained. The identity of UCP2 (UCP3) in HTP flow-through was verified using peptide mapping assisted by MALDI-TOF mass spectroscopy after in-gel trypsin cleavage of the PAGE-separated acetone-precipitated samples.
Fluorescent Monitoring of H ϩ Fluxes in Proteoliposomes-Valinomycin-induced H ϩ fluxes in the presence of various FAs were monitored by the SPQ quenching method (20, 22, 23, 37, 39 ) with 2 mM SPQ internally. Ethanol solutions of FAs were added to 25 l (ϳ1.5 mg) of vesicles in 2 ml of external medium (84.4 mM K 2 SO 4 , 28.8 mM TEA-TES with 9.2 mM TEA, pH 7.2, and 0.6 mM TEA-EGTA) and H ϩ efflux was initiated by 0.1 M valinomycin. Fluorescence was monitored on a RF5301 PC fluorimeter (Shimadzu, Japan), equipped with polarization filters (Polaroid) in cross-orientation in order to decrease light scattering. Fluorescence was calibrated to [H ϩ ] by adding KOH aliquots to proteoliposomes in the presence of 1 M nigericin, and H ϩ flux rates were calculated as previously described (39) . The internal volume was calculated from SPQ volume distribution (20, 22, 23, 39 ) assuming a total lipid content of 60.7 mg in 1 ml (1.5 mg in the assay) and typically amounted to ϳ1.2 l (mg of lipid) Ϫ1 . Assay for 3 H-labeled Nucleotide Binding-Klingenberg's anion exchange method was used to determine 3 H-labeled nucleotide binding (44) . Either, E. coli-expressed proteins were used, or the isolation of yeast-expressed UCP2 and UCP3 was modified while the HTP wash fractions were also taken. The samples were further desalted and concentrated using Amicon microconcentrators (cutoff M r 10,000), to obtain a concentrated micellar protein solution in 10 mM Na-MES, 1.5 mM TEA 2 SO 4 , pH 6.5. The optimum protein to nucleotide ratio was adjusted to give linear Scatchard plots (45 (50 l) or to the parallel sample series with 2.5 mM GTP (ATP, respectively). After 60 min of incubation at 20°C, the unbound nucleotides were removed by the sample passage through 1-ml spin columns containing Dowex, Cl Ϫ form. The flow-through samples were subjected to liquid scintillation counting. The data were calculated using Scatchard plot analysis (45) .
Assay for 3 H-labeled Nucleotide Binding in Mitochondria-Isolation of mitochondria from rat lung, kidney, skeletal muscle, and liver was performed essentially as described elsewhere (41) . Bovine serum albumin-washed mitochondria (0.2 mg of protein) were mixed with [ 3 H]GTP aliquots (8 -320 pmol and with 0.6 mM "cold" GTP in parallel series) and incubated for 30 min in 200 l of 100 mM sucrose, 20 mM Tris-HEPES, 1 mM EDTA, 2 M rotenone, 5 M CAT, pH 7.0. Mitochondria were then filtered through nitrocellulose filters (0.45-mm pore, Millipore). The filters were washed twice with sucrose medium and placed into scintil-lation solution. The measured radioactivity of the samples containing an excess of non-radioactive GTP was always subtracted, and Scatchard plots were generated (45) .
RESULTS

H
ϩ Efflux Induced by Fatty Acids in Proteoliposomes Containing UCP2 and UCP3- Fig. 1 , a and b, illustrates the monitoring of H ϩ fluxes induced by K ϩ diffusion potential in the presence of lauric acid in proteoliposomes containing the recombinant uncoupling proteins, UCP2 or UCP3. Both were able to mediate H ϩ efflux upon the addition of 0.1 M valinomycin to the vesicles pre-equilibrated with 200 M lauric acid. The lauric acid addition causes the interior acidification of vesicles, called flip-flop acidification, reflecting the redistribution of FA molecules in both leaflets of the lipid bilayer (46) . Note that the extent of this acidification is unchanged in the presence of ATP, reflecting the undistorted SPQ response. Consequently, we could detect that the observed H ϩ fluxes were up to 50% inhibited by various purine nucleotide (PN) di-and triphosphates (vide infra). High PN concentrations also decreased the extent of SPQ response to H ϩ efflux, which indicates that a single protein per vesicle exists in our preparation. Alternatively, if several proteins exist they have the same orientation. This is feasible because of our high lipid-to-protein ratio, 2 and such observations were made for years with UCP1 or plant UCP not only for SPQ monitoring of H ϩ flux, but also for Cl Ϫ and alkylsulfonate flux (22, 23, 37, 40, 47) .
Fig. 1 (a and b) illustrates the inhibition of the lauric acidinduced H
ϩ efflux in proteoliposomes containing UCP2 or UCP3. However, ATP did not affect the slow H ϩ efflux induced at a 10-fold higher valinomycin concentration by lauric acid in proteoliposomes containing the extract from the mitochondria of W303 yeast not expressing UCP2 or UCP3 (Fig. 1c) . The W303 extract was prepared and passed through an HTP column similar to that of yeast-expressed UCP2 or UCP3. The resulting FA-induced H ϩ efflux increased with increasing initial amount of W303 yeast mitochondria. It is likely mediated by yeast carriers of the HTP flow-through, such as the ADP/ ATP carrier (48) or the phosphate carrier (39, 49) . In turn, the ATP insensitivity of H ϩ efflux with the reconstituted W303 extract and only slight (Ͻ10%) inhibition of FA-induced H ϩ efflux in UCP2 or UCP3 proteoliposomes by CAT agaric acid, 3 or methylenediphosphonate suggest that the ATP-sensitive H ϩ fluxes in UCP2 (UCP3) proteoliposomes are indeed due to UCP2 (UCP3) function, respectively.
Various natural FAs were able to induce H ϩ efflux in proteoliposomes containing UCP2 (Table I) and UCP3. Among all tested FAs, the fastest H ϩ efflux was found for oleic acid and myristic acids followed by polyunsaturated FAs. Also the H ϩ efflux induced by PUFAs was inhibited up to 50% by the ATP present in the external medium ( Fig. 1d and vide infra). Similar results were found with UCP3. Moreover, additions of -6 PUFAs exhibited the highest extent of flip-flop acidification. Thus, cis-8,11,14-eicosatrienoic acid (C20:3 -6) had on average a double extent of flip-flop acidification when compared with lauric acid (Fig. 1, a and d) . This finding would suggest that the physicochemical properties of FA movement in the membrane and their partition coefficient K p could contribute to their maximum cycling rates. Also the flip-flop rate of fatty acids was previously found to increase with increasing unsaturation (50) . In order to elucidate the involved structure/kinetic relationships we further studied the kinetics of the FA activation of UCP2-mediated H ϩ efflux.
Kinetics of UCP2-mediated H
ϩ Efflux Induced by Lauric Acid-Kinetics of lauric acid activation of H ϩ efflux (FA cycling) in UCP2 proteoliposomes is illustrated in Fig. 2a . H ϩ efflux rates were evaluated with and without 2.5 mM ADP. Assuming Michaelis-Menten kinetics, we constructed EadieHofstee plots for total rates (right panel in Fig. 2a and Table I ) and for differential rates (not shown), when the rates measured with ADP were subtracted from the control rates. The kinetic parameters obtained for differential rates were used to construct the theoretical fit by the Michaelis-Menten equation (dotted line in Fig. 2a ). This fit reflects the kinetics of uniformly oriented UCP2 molecules with the PN binding site exposed outside. Mostly, these kinetics were similar to that measured with external ADP or ATP, which reflects the opposite UCP orientation.
The Eadie-Hofstee plot for the experiment with externally added ADP is nearly parallel to the control plot (Fig. 2a) . Thus, kinetics in the absence and presence of ADP exhibits almost equal K m , while V max with ADP was about half of the control. As with UCP1, this fact reflects a noncompetitive and perhaps an allosteric type of nucleotide inhibition. Although subject to errors, the differential rates also yielded an Eadie-Hofstee plot parallel with those for control or ADP. The apparent K m values for lauric acid and UCP2 or UCP3 (Table I) were higher than those found for UCP1 (22) . Note, that this has been also observed for CoQ 10 -activated E. coli-expressed UCP2 and UCP3 (21) .
ϩ Efflux Induced by Naturally Abundant Fatty Acids-Among naturally abundant FAs, myristic acid, palmitic acid (Fig. 2b) , oleic acid (Fig. 2c) , linoleic acid, and arachidonic acid (Fig. 2d ) exhibited the ability to induce H ϩ efflux in proteoliposomes containing UCP2 (Table I) (Table I) , the densities in UCP2 or UCP3 proteoliposomes were much higher than the densities for background H ϩ fluxes in protein-free liposomes. They were usually also higher than the H ϩ flux densities estimated in the vesicles containing extracts from W303 yeast mitochondria (Table I ). The EadieHofstee plots constructed for total H ϩ fluxes in micromoles of H ϩ ⅐min Ϫ1 ⅐(mg of protein) Ϫ1 were again parallel with those for H ϩ fluxes in the presence of external ATP or ADP and largely similar differential rates (dotted lines in Fig. 2, a-d) .
The apparent affinity for various FAs (taken as the inverse K m , Table I ) was quite similar but decreased in order for heptylbenzoic Ͼ palmitic Ͼ lauric Ͼ linoleic Ͼ arachidonic Ͼ oleic Ͼ myristic acid. Note that PUFAs (vide infra) and nonphysiological heptylbenzoic acid exhibited higher affinity than naturally abundant FAs. The V max values and turnover numbers per dimer are also listed in Table I . The turnovers represent the minimum estimates, since not all measured protein is likely to be active. Among abundant FAs, the highest turnover was found for oleic acid, while it decreased for myristic Ͼ linoleic Ͼ arachidonic Ն palmitic Ն lauric acid. Heptylbenzoic acid exhibited the lowest evaluated turnover. Only 10% H ϩ flux was observed for caprylic acid and less than 5% for 12-hydroxylauric acid, an inactive FA which is unable to flip-flop across the lipid bilayer (46) . Note that H ϩ fluxes in the absence of FAs amounted to 7-10% of V max for lauric acid (Table I) 
Do Exceptional Activating Fatty Acids Exist for UCP2?-
Among the naturally abundant FAs tested as the above initial series, we have found almost no "exceptional" FAs that would induce significantly higher H ϩ fluxes in UCP2 proteoliposomes or a high apparent affinity, given by a very low K m . Table I indicates that oleic and myristic acid exhibited the highest rates, but also a quite high K m , reflecting the low affinity. Unsaturation was not a major factor, since arachidonic acid (C20:4 -6) behaved similarly to palmitic and lauric acid. Nevertheless, we found more potent FAs when the kinetics of PUFAs was tested. Thus, cis-8,11,14-eicosatrienoic (or dihomo-␥-linolenic, C20:3 -6) and cis-6,9,12 octadecatrienoic (␥-linolenic, C18:3 -6) were found to induce very fast H ϩ efflux in UCP2 proteoliposomes. However, their kinetics exhibited the lowest K m values found: 20 and 29 M, respectively ( Fig. 3 and Table I ). Similar results were found for UCP3. Also, cis -5,8,11,14,17- Table I ) and cis -4,7,10,13,16,19 docosahexaenoic acid (C22:6 -3) were more efficient than FAs of the basic series of naturally abundant FAs. EPA exhibited the third highest apparent affinity (Table I) .
No Nucleotide Inhibition of UCP2 and UCP3-Also the above kinetic data demonstrated that the observed H ϩ fluxes were up to 50% inhibited by various PN di-and triphosphates. 4 The inability of complete inhibition by the external PN can be explained by two equally distributed orientations of UCP molecules in the membrane, with PN binding sites exposed outside and inside (22) . Hence, we could evaluate the inhibitory dose responses for lauric acid-induced H ϩ uniport while assuming a decrease to a 50% rate as 100% inhibition. Stock nucleotide solutions that are usually acidic had to be buffered by Tris base, and assay pH was carefully maintained at 7.2. Otherwise, artificial "inhibition" was observed because of a decrease in UCP2 (a and d), UCP3 (b) , or hydroxylapatite-passed extract from W303 yeast mitochondria (c).
rate by acidic pH. For reconstituted UCP2, the lowest K i was exhibited by ADP (350 M, Fig. 4 ), while ATP exhibited higher K i (445 M) reflecting a slightly lower affinity of ATP to UCP2 (Fig. 4) . These results were confirmed by three independent experiments. The apparent affinity for GTP was slightly lower than for ATP (Table II) and for GDP it was even lower (Table  II) . The lowest affinity was found for AMP ( Fig. 4 and Table II) ; indeed it is similar to the low affinity of AMP and GMP versus ATP or GTP, previously documented for UCP1 (51, 52) . Similar results were obtained with UCP3 (Table II ). The magnitudes of K i values for PN inhibition are higher than those found for UCP1, as also tested with recombinant yeast-expressed UCP1 (Table II) , but are lower than those reported for E. coli-expressed protein (20 Fig. 5 , demonstrating binding under conditions eliminating possible contribution of the ADP/ATP carrier (CAT prevents nucleotide binding to this carrier and GTP has a much lower affinity to it). The observed saturated binding was partially prevented by the unlabeled (cold) GTP or ATP, respectively, but [ 3 H]GTP binding was also prevented by ATP and ADP (not shown). Binding constant K d values amounting to the average of ϳ1.5 M (Table III) were derived from the Scatchard plots for both, the GTP-sensitive portion of Table III ) to 1.3 M with CAT, whereas the apparent number of binding sites decreased from 1.5 per UCP2 monomer by ϳ10 -20%. Similar data but with lower affinities (higher K d values) and lower numbers of binding sites were obtained for UCP2 and UCP3 expressed in E. coli ( Fig. 6 and Table III) . CAT had no effect (Fig. 6) , thus reflecting that no ADP/ATP carrier contamination is possible with this expression (as well as no Coenzyme Q carryover). Despite this, the obtained K d values were three times higher, possibly also caused by the remaining lauroylsarcosinate present. We can conclude that the observed saturated binding reflects the nucleotide binding sites of recombinant UCP2 and UCP3 in both cases of expression. The higher affinity and higher proportion of binding sites obtained for yeastexpressed proteins reflect the advantage of this system and the lipid protection used.
[ 3 
H]GTP Binding to Isolated Mitochondria of Several Tissues-
In order to demonstrate the existence of native UCPs in intact tissues and to show the relevancy of the binding method not only for recombinant, but also for native proteins, we have evaluated [ 3 H]GTP binding in the presence of CAT in mitochondria isolated from rat liver, skeletal muscle, kidney, and lung (Fig. 7) . In agreement with the findings of Pecqueur et al. (19) , we found the highest number of tions between the numbers of [ 3 H]GTP binding sites in the studied tissues correlate well to the proportions of UCP2 mRNA typically found in these tissues (5) (6) (7) 19 Table I. FIG . 2. Kinetics of presumed fatty acid cycling mediated by  UCP2 lauric acid (a), palmitic acid (b), oleic acid (c), arachidonic acid (d) . Left part should represent a minor portion. Consequently, these data represent the first demonstration of the existence of high affinity nucleotide binding to native UCP2 (UCP3).
DISCUSSION
In this work we have evaluated in detail the possible phenotypes of the novel uncoupling proteins UCP2 and UCP3. We have identified their best up-to-date known activating and inhibitory ligands. We have demonstrated that two (C18 and C20) -6 PUFAs are the most potent activators of UCP2 (UCP3), whereas among purine nucleotides, ADP is the most potent inhibitor. We have for the first time demonstrated the binding of natural 3 H-labeled nucleotides to recombinant UCP2 (UCP3) proteins and to the mitochondria of several tissues.
Concerning activating FAs, we have clearly demonstrated that all physiologically abundant long chain FAs, saturated or unsaturated, activate H ϩ translocation in UCP2 and UCP3
proteoliposomes. This is demonstrated by the parameters of their activating (FA cycling) kinetics. We cannot explain why Rial et al. (36) could not find any response with their tested FAs, except for the all-trans-retinoic acid in yeast mitochondria of yeast-expressing UCP2. Among our tested FAs, we have found that oleic acid exhibited the highest rate, but -6 PUFAs, such as cis-8,11,14-eicosatrienoic (C20:3 -6) and cis-6,9,12 octadecatrienoic (C18:3 -6) exhibited both high V max and the highest apparent affinity (1/K m ). As such they were very efficient in inducing H ϩ uniport mediated by UCP2. Hence, we have shown that more efficient FAs do indeed exist and are activating UCP2-mediated H ϩ uniport in lower concentrations (amounts) than that required for other natural FAs. Their low in vivo abundance is balanced by their high activating profile. This is valid for the two -6 PUFAs, which were identified by us as the best UCP2 activators. For example, the typical content as 1.9 and 2.9 g of C20:3 -6, or 0.8 and 0.4 g of C18:3 -6, was identified per mg of phospholipids in rat liver and kidney, respectively (54) . The amount of C20:3 -6 in human plasma phospholipids is equivalent to 100 M (55). One can speculate that if 10% of these amounts would be cleaved off, a substantial activation of UCP2 will occur. A slightly lower efficiency with regard to UCP2 was found for -3 PUFAs, EPA (C20:5 -3) and docosahexaenoic acid (C22:6 -3), but because of the very high content of the latter in the brain or retina tissues (56) , activation of UCP2 by C22:6 -3 is very plausible. The efficiency of C20:5 -3 and C22:6 -3 was still higher than that of arachidonic or oleic, or lauric and palmitic acid (equally effective as lauric). Our results have a great physiological relevance, since -6 PUFAs are among the most efficient activators of PPAR␤ (17) and together with -3 PUFAs also to potent activators of PPAR␥ (18) and PPAR␣ (57) . In conclusion, our findings suggest their possible dual role in activating both UCP2 (UCP3) expression and the uncoupling activity.
Our results have also shown that protonophoric phenotypes of UCP2 and UCP3 do not differ qualitatively from the UCP1 phenotype. The per dimer turnovers (estimated from V max and total protein) fall into the range of hundreds per second (Table  II) (21) .
Concerning PN inhibition, the derived K i values for UCP2 and UCP3 were higher than those for UCP1 in our reconstituted system, but all K i values for ATP and ADP were within the range of several hundred micromolar. We must admit that sulfate used in our assay media strongly decreases the PN affinity to UCP1 (25) and presumably also to UCP2/UCP3, which might explain the discrepancies between our K i values and those measured by Klingenberg and co-workers (21, 58) and partly also between the K i values (Table II) (Table III) . We chose sulfate to ensure that the anion used would be membrane impermeant, would not quench the SPQ probe, and that UCPs would not transport it. Thus, sacrificing the efficiency of nucleotide inhibition, we ensured high K ϩ diffusion potential and the correct probe response. Our medium may better simulate in vivo conditions. We have also demonstrated that ADP is a slightly stronger UCP2 inhibitor than ATP. The same finding has previously been reported for UCP3 (58) . GTP and GDP exhibited a slightly lower inhibitory ability. However, the differences between ATP and GTP were not found for the binding constant K d . It is also not certain whether the observed small difference in ATP and ADP affinities in vitro can account for the suggested in vivo activation of UCP3 by the increased ATP/ADP ratio (58) simply because of higher ADP affinity.
We have also confirmed the existence of PN interaction with UCP2 (UCP3) by direct binding experiments using Nevertheless, the affinity derived as reciprocal K d is about three times higher for the native UCP2 in mitochondria than for recombinant yeast-expressed UCP2. Obviously, the natural insertion of UCP2 molecule in the internal membrane is superior to the micellar solution.
The existence of high affinity [ 3 H]GTP binding sites in mitochondria suggests that these sites may indeed reflect the binding to native UCP2 (UCP2 plus UCP3 in skeletal muscle mitochondria). This conclusion is strongly supported by our finding of the highest number of [ 3 H]GTP binding sites in the mitochondria of tissues where UCP2 content was reported to be high, i.e. in lung (19) and kidney (27) . On the contrary, we found a ϳ10 times lower number of [ 3 H]GTP binding sites in the mitochondria of liver, an organ which has almost no UCP2 expression (6, 7), unless it is stimulated, e.g. by cytokines (2, 9) . This fact again suggests that the detected [ 3 H]GTP binding sites could be predominantly formed by UCP2. Surprisingly, skeletal muscle mitochondria, presumably containing both UCP2 and UCP3, exhibited only a slightly higher content of [ 3 H]GTP binding sites than liver mitochondria. However, this estimate fits well with protein measurements using antibodies (19) . In conclusion, the maximum UCP2 content found in lung mitochondria (ϳ200 pmol/mg of protein, Fig. 7 ) is about four times less abundant than the content of UCP1 in BAT mitochondria (53) . In skeletal muscle, the UCP2 ϩ UCP3 content derived from the total number of [ 3 H]GTP binding sites was ϳ7 times smaller than the UCP2 in the lung, and in the liver, UCP2 is even less abundant. The finding of small amounts of UCP2 in isolated mitochondria supports the concept of UCP2 (UCP3) as a stress protein, which can be elevated as required under various physiological situations (2, 5) .
It would seem to be trivial to note that no superoxide activation was required in our experiments to demonstrate PN binding or FA-activated H ϩ uniport. But, since other investi- gators claim that only under such activation can PN inhibition of FA-induced uncoupling be observed (27) , we must stress this point. In conclusion, we have demonstrated that yeast-expressed UCP2 and UCP3 are able to mediate PN-sensitive H ϩ transport in the presence of FAs and that recombinant yeast-or E. coli-expressed UCP2 and UCP3 do indeed bind purine nucleotides. The latter property is reflected in vivo by the various number of PN binding sites in the mitochondria of various tissues. Their number, and hence the amount of UCP2 (UCP3) is, however, quite low. Except for lung mitochondria, it is at least 10 times lower than the amount of UCP1 in BAT mitochondria. Despite this fact, in vivo, when not all FAs are metabolized or when FAs would be cleaved off lipids (e.g. by phospholipase C), a certain non-zero uncoupled state may exist in all types of mitochondria. Such a weak uncoupling state would be enabled by the lowering (modulating) PN affinity due to elevated concentrations of anions, Mg 2ϩ , or other putative modulators of PN inhibition. The resulting weak uncoupling also prevents the excessive production of reactive oxygen species. Yet, the unknown regulatory mechanisms may further release PN inhibition to achieve a higher or complete activation of UCPn-mediated uncoupling. The states of higher uncoupling would then represent the specific thermogenic roles of UCPn in different tissues, such as tissue-specific adaptive thermogenesis, and simultaneously, a state with a very low mitochondrial production of the reactive oxygen species.
